methoxyhydroxyphenylglycol has been researched along with Dyskinesia Syndromes in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doongaji, DR; Jeste, DV; Linnoila, M | 1 |
| Shapiro, K; Sharpless, NS; Thal, LJ; Waltz, JM; Wolfson, LI | 1 |
| Fujii, S; Hatanaka, Y; Yamamoto, M | 1 |
| Ekman, R; Fall, PA; Granérus, AK; Thorell, LH; Wålinder, J | 1 |
| Korf, J; Van Praag, HM | 1 |
| Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
| Ogawa, N; Ujike, H; Yamamoto, M | 1 |
| Butler, IJ; Caskey, TC; Jankovic, J; Stout, JT | 1 |
8 other study(ies) available for methoxyhydroxyphenylglycol and Dyskinesia Syndromes
| Article | Year |
|---|---|
Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Norepinephrine; Schizophrenia | 1984 |
Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia.
Topics: Adolescent; Adult; Cerebral Ventricles; Child; Child, Preschool; Dystonia; Female; Glycols; Humans; Hydrocephalus; Male; Methoxyhydroxyphenylglycol; Movement Disorders; Norepinephrine | 1983 |
Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy.
Topics: Antiparkinson Agents; Droxidopa; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Supranuclear Palsy, Progressive | 1997 |
ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides.
Topics: Aged; Aged, 80 and over; Biogenic Monoamines; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Neuropeptides; Parkinson Disease; Time Factors | 1995 |
Neuroleptics, catecholamines, and psychoses: a study of their interrelations.
Topics: Adolescent; Adult; Brain; Brain Chemistry; Catecholamines; Chlorpromazine; Depression, Chemical; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Norepinephrine; Piperazines; Psychotic Disorders; Stimulation, Chemical; Tranquilizing Agents | 1975 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
Topics: Droxidopa; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; MMPI; Movement Disorders; Serine | 1985 |
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
Topics: Carbidopa; Catecholamines; Child; Child, Preschool; Fluphenazine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lesch-Nyhan Syndrome; Levodopa; Male; Methoxyhydroxyphenylglycol; Movement Disorders; Self Mutilation; Tetrabenazine | 1988 |